4//SEC Filing
Kartsaklis Athena 4
Accession 0001493152-18-001520
CIK 0000764195other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 1:51 PM ET
Size
6.4 KB
Accession
0001493152-18-001520
Insider Transaction Report
Form 4
Kartsaklis Athena
SVP Finance, CCO
Transactions
- Award
Option (Right to Buy Common Shares)
2018-01-23+75,000→ 75,000 totalExercise: $4.25Exp: 2028-01-23→ Common Shares (75,000 underlying)
Footnotes (3)
- [F1]Exercise price is in Canadian dollars. United States dollars equivalent is shown using the closing foreign exchange rate on the Grant Date (as defined below).
- [F2]The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 23, 2018 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 23, 2018 (the "Option Agreement"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date.
- [F3]The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement.
Documents
Issuer
VBI Vaccines Inc/BC
CIK 0000764195
Entity typeother
Related Parties
1- filerCIK 0001730501
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 1:51 PM ET
- Size
- 6.4 KB